Engineering vaccines with heterologous B and T cell epitopes using immunoglobulin genes


Antibodies engineered in their variable domain to express epitopes of heterologous antigens—antigenized antibodies—function as immunogens. Only the third complementarity-determining region (CDR3) of the H chain has been used as the site of epitope expression, as this loop has the highest natural variability in length and amino acid composition. We… (More)
DOI: 10.1038/nbt0997-882


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics